Novacyt S.A. (FRA:NYZ)
Germany · Delayed Price · Currency is EUR 0.3845
-0.0105 (-2.66%)
At close: Jan 30, 2026
Novacyt Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 19.45 | 19.63 | 10.62 | 21.04 | 92.6 | 277.2 | |
Revenue Growth (YoY) | 39.55% | 84.82% | -49.52% | -77.28% | -66.59% | 2317.20% |
Cost of Revenue | 8.23 | -11.51 | 7.57 | 15.29 | 29.11 | 65.98 |
Gross Profit | 11.22 | 31.14 | 3.05 | 5.75 | 63.5 | 211.22 |
Selling, General & Admin | 22.38 | 44.8 | 15.86 | 16.92 | 22.09 | 34.75 |
Research & Development | 3.48 | 2.77 | 2.85 | 5.05 | 4.65 | 1.63 |
Other Operating Expenses | -0.22 | 0.24 | 0.17 | 7.18 | -0.27 | 0.15 |
Operating Expenses | 25.64 | 47.8 | 18.88 | 29.14 | 26.47 | 36.53 |
Operating Income | -14.42 | -16.66 | -15.83 | -23.39 | 37.03 | 174.69 |
Interest Expense | -0.64 | -0.68 | -0.45 | -0.63 | -0.07 | -1.6 |
Interest & Investment Income | 0.85 | 1.21 | 2.03 | - | - | - |
Currency Exchange Gain (Loss) | -1.47 | -2.69 | -1.03 | - | -1.88 | -0.32 |
Other Non Operating Income (Expenses) | 0.09 | 0.08 | 0.44 | 3.97 | 0.2 | -0.35 |
EBT Excluding Unusual Items | -15.58 | -18.75 | -14.84 | -20.05 | 35.29 | 172.42 |
Merger & Restructuring Charges | -1.62 | -1.31 | -3.3 | - | -0.42 | -0.29 |
Impairment of Goodwill | -11.24 | -11.24 | -4.11 | - | -4.02 | -5.77 |
Gain (Loss) on Sale of Assets | -0.93 | -0.86 | -0.35 | - | - | -0.08 |
Asset Writedown | - | - | - | - | -26.1 | -1.11 |
Legal Settlements | - | - | - | - | 0.07 | - |
Other Unusual Items | 0.1 | -7.27 | -1.86 | - | -10.47 | - |
Pretax Income | -29.27 | -39.43 | -24.46 | -20.05 | -5.66 | 165.17 |
Income Tax Expense | -0.78 | -0.73 | -0.35 | 2.15 | 0.35 | 32.75 |
Earnings From Continuing Operations | -28.49 | -38.7 | -24.11 | -22.2 | -6.01 | 132.42 |
Earnings From Discontinued Operations | -1.91 | -3.06 | -4.18 | -3.53 | -3.72 | - |
Net Income | -30.4 | -41.76 | -28.29 | -25.73 | -9.73 | 132.42 |
Net Income to Common | -30.4 | -41.76 | -28.29 | -25.73 | -9.73 | 132.42 |
Shares Outstanding (Basic) | 71 | 71 | 71 | 71 | 71 | 68 |
Shares Outstanding (Diluted) | 71 | 71 | 71 | 71 | 71 | 68 |
Shares Change (YoY) | - | - | - | - | 3.58% | 49.10% |
EPS (Basic) | -0.43 | -0.59 | -0.40 | -0.36 | -0.14 | 1.94 |
EPS (Diluted) | -0.44 | -0.59 | -0.40 | -0.36 | -0.14 | 1.94 |
Free Cash Flow | -6.93 | -11.1 | -25.96 | -13.89 | 11.92 | 101.96 |
Free Cash Flow Per Share | -0.10 | -0.16 | -0.37 | -0.20 | 0.17 | 1.50 |
Gross Margin | 57.70% | 158.65% | 28.70% | 27.31% | 68.57% | 76.20% |
Operating Margin | -74.11% | -84.87% | -149.02% | -111.18% | 39.99% | 63.02% |
Profit Margin | -156.30% | -212.73% | -266.38% | -122.29% | -10.51% | 47.77% |
Free Cash Flow Margin | -35.65% | -56.57% | -244.45% | -65.99% | 12.87% | 36.78% |
EBITDA | -8.4 | -11.27 | -13.03 | -15.48 | 38.53 | 175.64 |
EBITDA Margin | -43.19% | -57.41% | -122.65% | -73.55% | 41.60% | 63.36% |
D&A For EBITDA | 6.01 | 5.39 | 2.8 | 7.92 | 1.5 | 0.95 |
EBIT | -14.42 | -16.66 | -15.83 | -23.39 | 37.03 | 174.69 |
EBIT Margin | -74.11% | -84.87% | -149.02% | -111.18% | 39.99% | 63.02% |
Effective Tax Rate | - | - | - | - | - | 19.83% |
Advertising Expenses | - | 0.34 | 0.26 | - | 0.74 | 0.31 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.